HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Volker Gerdts Selected Research

Vaccine Adjuvants

1/2022Assessing the In Vivo Effectiveness of Cationic Lipid Nanoparticles with a Triple Adjuvant for Intranasal Vaccination against the Respiratory Pathogen Bordetella pertussis.
1/2018Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs.
7/2010Differential activation and maturation of two porcine DC populations following TLR ligand stimulation.
3/2009Strategies to link innate and adaptive immunity when designing vaccine adjuvants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Volker Gerdts Research Topics

Disease

38Infections
04/2024 - 04/2006
13Whooping Cough (Pertussis)
01/2022 - 04/2006
8Communicable Diseases (Infectious Diseases)
01/2021 - 12/2007
6COVID-19
01/2024 - 01/2021
4Virus Diseases (Viral Diseases)
07/2021 - 06/2009
4Human Influenza (Influenza)
02/2021 - 08/2010
4Pleuropneumonia
07/2020 - 11/2015
3Reinfection
01/2024 - 10/2017
3Inflammation (Inflammations)
01/2023 - 11/2015
3Zika Virus Infection
01/2020 - 01/2018
3Respiratory Tract Infections (Respiratory Tract Infection)
01/2018 - 04/2006
2Bacterial Infections (Bacterial Infection)
01/2021 - 12/2008
2Lumpy Skin Disease
11/2015 - 05/2013
1Ectopic Pregnancy
04/2024
1Pelvic Pain
04/2024
1Infertility (Sterility)
04/2024
1Post-Acute COVID-19 Syndrome
01/2024
1Coinfection
01/2023
1Convalescence
01/2022
1Frailty
07/2021
1Influenza in Birds (Avian Flu)
01/2020
1Mycobacterium Infections (Infections, Mycobacterium)
01/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Orthomyxoviridae Infections
01/2018
1Persistent Infection
11/2017
1Parasitic Diseases (Parasitic Disease)
01/2017
1Reproductive Tract Infections
01/2017
1Neoplasms (Cancer)
01/2014
1Pneumonia (Pneumonitis)
07/2013
1Rift Valley Fever
05/2013
1Peste-des-Petits-Ruminants
05/2013
1Autoimmune Diseases (Autoimmune Disease)
12/2011
1Porcine Reproductive and Respiratory Syndrome (PRRS)
07/2010
1Necrosis
03/2010

Drug/Important Bio-Agent (IBA)

33VaccinesIBA
01/2024 - 10/2007
7CytokinesIBA
01/2024 - 06/2009
6AntibodiesIBA
01/2022 - 05/2006
5AntigensIBA
01/2023 - 08/2010
4Anti-Bacterial Agents (Antibiotics)IBA
04/2024 - 10/2014
4Neutralizing AntibodiesIBA
01/2024 - 10/2022
4Immunoglobulin G (IgG)IBA
01/2023 - 05/2006
4Antiviral Agents (Antivirals)IBA
01/2023 - 01/2020
4InterferonsIBA
01/2023 - 07/2013
4CPG-oligonucleotideIBA
04/2022 - 06/2009
4Peptides (Polypeptides)IBA
01/2022 - 03/2009
4Vaccine AdjuvantsIBA
01/2022 - 03/2009
4Proteins (Proteins, Gene)FDA Link
03/2016 - 03/2010
3Subunit VaccinesIBA
07/2020 - 01/2014
3Interferon-alpha (Interferon Alfa)IBA
01/2020 - 01/2019
2Influenza Vaccines (Influenza Vaccine)FDA Link
02/2021 - 01/2018
2Interferon Type IIBA
01/2021 - 11/2017
2InterleukinsIBA
01/2020 - 03/2010
2Interleukin-27 (Interleukin 27)IBA
01/2020 - 01/2020
2Hydrocortisone (Cortisol)FDA LinkGeneric
01/2019 - 01/2018
2Lysergic Acid Diethylamide (LSD)IBA
11/2015 - 05/2013
2OligodeoxyribonucleotidesIBA
07/2013 - 06/2009
2Immunoglobulin A (IgA)IBA
06/2013 - 05/2006
2beta-DefensinsIBA
08/2008 - 04/2006
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2024
1Broadly Neutralizing AntibodiesIBA
01/2023
1N-(2-cyanoethylene)urea (BA 1)IBA
01/2023
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
11/2022
1EpitopesIBA
01/2022
1Pertussis VaccineIBA
01/2022
1ProteomeIBA
01/2022
1LipidsIBA
01/2022
1Antimicrobial PeptidesIBA
01/2021
1CytosineIBA
01/2020
1Phosphates (Orthophosphate)IBA
01/2020
1Bacterial VaccinesIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1interleukin-21 (interleukin 21)IBA
01/2020
1GuanineIBA
01/2020
1SodiumIBA
01/2018
1OvalbuminIBA
10/2017
1cyclic diadenosine phosphateIBA
10/2017
1Interferon-gamma (Interferon, gamma)IBA
01/2017
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1Type III Secretion SystemsIBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1delta inulinIBA
01/2017
1IDR 1002IBA
01/2017
1Interleukin-12 (IL 12)IBA
01/2017
1ISCOMATRIXIBA
01/2017
1Capsid Proteins (Capsid Protein)IBA
12/2015
1Inactivated VaccinesIBA
12/2015
1SolutionsIBA
10/2014
1ChemokinesIBA
08/2014
1Lipid AIBA
02/2014
1bis(3',5')-cyclic diguanylic acidIBA
01/2014
1Guanosine Triphosphate (GTP)IBA
05/2013
1Indicators and Reagents (Reagents)IBA
03/2012
1pertussis toxoidIBA
09/2011
1LigandsIBA
07/2010
1Pattern Recognition ReceptorsIBA
07/2010
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2010

Therapy/Procedure

1Treatment Delay
04/2024
1Therapeutics
01/2024
1Long-Term Care
07/2021